GAM Holding’s Pacira BioSciences PCRX Stock Holding History

GAM Holding’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-12,404	Closed	-$539K	–	874
2019 Q2	$539K	Buy	+12,404	New	+$527K	0.02%	660
2016 Q1	–	Sell	-47,700	Closed	-$3.66M	–	1033
2015 Q4	$3.66M	Hold	47,700	–	–	0.06%	345
2015 Q3	$1.96M	Hold	47,700	–	–	0.03%	491
2015 Q2	$3.37M	Buy	47,700 +17,000	+55%	+$1.34M	0.05%	381
2015 Q1	$2.73M	Buy	30,700 +10,700	+54%	+$1.09M	0.04%	433
2014 Q4	$1.77M	Buy	+20,000	New	+$1.89M	0.03%	542

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GAM Holding's PCRX Position: Q3 2019 in Review

GAM Holding sold out of Pacira BioSciences (PCRX) in Q3 2019, closing a stake of 12,404 shares — an estimated $539K sold.

GAM Holding first reported a position in PCRX in Q4 2014 and held it in 6 quarters. The position peaked at $3.66M in Q4 2015. 211 funds tracked by Wall St. Rank hold PCRX as of Q3 2019.

GAM Holding reported no remaining Pacira BioSciences position as of Q3 2019 after selling out during the quarter.
GAM Holding sold 12,404 Pacira BioSciences shares in Q3 2019, an estimated $539K.
GAM Holding first reported a position in Pacira BioSciences in Q4 2014 and held it in 6 quarters.
GAM Holding's Pacira BioSciences position peaked at $3.66M in Q4 2015.
211 funds tracked by Wall St. Rank held Pacira BioSciences as of Q3 2019.

Based on GAM Holding's 13F filing for Q3 2019, filed 8 Nov 2019.